← Back to Search

Implementation Facilitation for Opioid Medication Treatment (CONDUIT Trial)

N/A

Waitlist Available

Led By William C Becker, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up course of 3-year study

Awards & highlights

CONDUIT Trial Summary

This trial is combining the efforts of six different pilot projects in order to create a single project that will help to increase access to and use of medications for opioid use disorder (MOUD) and alternative therapies for pain in the Veterans Health Administration (VHA) nationally.

Eligible Conditions

Opioid Medication Assisted Treatment

CONDUIT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ course of 3-year study

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~course of 3-year study

This trial's timeline: 3 weeks for screening, Varies for treatment, and course of 3-year study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cost of implementation

Elements of program maintained, including adaptations

Facilitators and barriers to implementation of MOUD

+7 more

Secondary outcome measures

Percentage of patients with OUD who experienced a fatal opioid-related or other drug overdose during implementation

Percentage of patients with OUD who experienced opioid-related or other drug overdose during implementation

Use of sedative prescriptions during implementation among patients with OUD

+1 more

CONDUIT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Implementation FacilitationExperimental Treatment1 Intervention

The foundation of CONDUIT's implementation activities are the structured interactions between external facilitation teams and internal facilitation teams. A core set of internal facilitation activities will be used across all facilitation teams, and external facilitation teams will use additional activities based on the needs of their sites or clinical settings.

Group II: Comparison CohortActive Control1 Intervention

All other sites in VA not receiving CONDUIT implementation support or participating in other dedicated MOUD implementation activities during the same time period

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,612 Previous Clinical Trials

3,300,909 Total Patients Enrolled

William C Becker, MDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT

2 Previous Clinical Trials

51 Total Patients Enrolled

Media Library

Implementation Facilitation Clinical Trial Eligibility Overview. Trial Name: NCT04178551 — N/A

Opioid Medication Treatment Research Study Groups: Comparison Cohort, Implementation Facilitation

Opioid Medication Treatment Clinical Trial 2023: Implementation Facilitation Highlights & Side Effects. Trial Name: NCT04178551 — N/A

Implementation Facilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04178551 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for participants in this clinical experiment?

"Per the information listed on clinicaltrials.gov, this trial is not currently enrolling participants. This scientific experiment was first posted in October 2019 and last updated in October 2022; however, there are 291 other studies actively seeking patients at this time."

Answered by AI

At which sites is the management of this clinical trial being conducted?

"Patients can enroll at 14 different sites, including Maine VA Medical Center in Togus, VA Boston Healthcare System Jamaica Plain Campus in Boston, and Birmingham VA Medical Center in Birmingham. Additionally there are 11 more locations available for study participation."

Answered by AI

What are the fundamental goals of this experiment?

"The primary aim of the trial is to evaluate maintenance levels over 6 months post-implementation, as assessed by the Expert Recommendations for Implementing Change (ERIC) survey. Additionally, number of VISTA x-waivered providers post-implementation will be observed and compared across facilities regarding implementation strategies used during this period. Finally, opioid or other drug overdoses in patients with OUD following intervention are also included among secondary outcomes which will be sourced from electronic health records."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Consortium to Disseminate and Understand Implementation of Opioid Use Disorder Treatment

2019. "Consortium to Disseminate and Understand Implementation of Opioid Use Disorder Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04178551.